Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic Inc (NQ: HOLX )

72.08 +0.67 (+0.94%)
Streaming Delayed Price Updated: 10:31 AM EDT, Aug 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hologic Inc

< Previous 1 2 3 Next >
Hologic's Return On Capital Employed Overview
Pulled from Benzinga Pro data, Hologic (NASDAQ:HOLX) posted Q3 earnings of $228.40 million, an increase from Q2 of 49.88%. Sales dropped to $1.00 billion, a 30.15% decrease between quarters. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
Upgrades 
Via Benzinga
Analyst Ratings for Hologic
Within the last quarter, Hologic (NASDAQ:HOLX) has observed the following analyst ratings: 
Via Benzinga
Expert Ratings for Hologic
Analysts have provided the following ratings for Hologic (NASDAQ:HOLX) within the last quarter: 
Via Benzinga
Lower COVID-19 Assay Sales Weighs On Hologic's Q2 Revenue
 
Via Benzinga
Expert Ratings for Hologic
Analysts have provided the following ratings for Hologic (NASDAQ:HOLX) within the last quarter: 
Via Benzinga
7 Nasdaq Stocks Trading at a Huge Discount Right Now
With the markets performing worse than they have in years, finding Nasdaq stocks trading at a discount is easier than ever. 
Via InvestorPlace
CNBC's Final Trades: Charles Schwab And These 3 Medical Stocks
On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said Charles Schwab Corporation (NYSE: SCHW) is trading at 14 times next year’s earnings. 
Via Benzinga
15 Stocks Moved By Traders on 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The... 
Via Benzinga
Hologic's Return On Capital Employed Overview
Pulled from Benzinga Pro data, Hologic (NASDAQ:HOLX) posted Q2 earnings of $455.70 million, an increase from Q1 of 8.71%. Sales dropped to $1.44 billion, a 2.38% decrease between quarters. 
Via Benzinga
Hologic: Q1 Earnings Insights
Hologic (NASDAQ:HOLX) reported its Q1 earnings results on Wednesday, February 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Raymond James Maintains Outperform Rating for Hologic: Here's What You Need To Know
Raymond James has decided to maintain its Outperform rating of Hologic (NASDAQ:HOLX) and lower its price target from $84.00 to $83.00. Shares of Hologic are trading down 2.08% over the last 24 hours,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
Upgrades 
Via Benzinga
7 S&P 500 Stocks That Have Raised Their Guidance in 2022
The number of companies raising guidance in 2022 has been slower than usual. Here are seven S&P 500 stocks that have upped guidance. 
Via InvestorPlace
Death Cross Looms Over Hologic Investors
If history is any guide, there may be trouble ahead for shares of Hologic (NASDAQ:HOLX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
Analyst Ratings For Hologic
Over the past 3 months, 5 analysts have published their opinion on Hologic (NASDAQ:HOLX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Complete List: Here Are All The Companies With Super Bowl LVI Commercials
Super Bowl LVI aired Sunday on NBC, a unit of Comcast Corp (NASDAQ: 
Via Benzinga
Looking Into Hologic's Return On Capital Employed
According to Benzinga Pro, during Q1, Hologic (NASDAQ:HOLX) earned $499.20 million, a 51.82% increase from the preceding quarter. Hologic also posted a total of $1.47 billion in sales, a 11.69%... 
Via Benzinga
Hologic Q1 FY22 Sales Decline 9% On Lower COVID-19 Assay Sales; Issues Upbeat FY22 Outlook
Hologic Inc (NASDAQ: HOLX) reported  
Via Benzinga
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
14 Stocks in the Healthcare Sector
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%. 
Via Talk Markets
Earnings Scheduled For February 2, 2022
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is likely to report quarterly earnings at $1.57 per share on revenue of $24.59 billion. 
Via Benzinga
A Peek Into The Markets: US Stock Futures Edge Higher; Crude Oil Up 0.5%
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the three major averages recorded losses last week. Investors are awaiting earnings... 
Via Benzinga
5 Stocks To Watch For January 10, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects Commercial Metals Company (NYSE: CMC) to report quarterly earnings at $1.21 per share on revenue... 
Via Benzinga
Price Over Earnings Overview: Hologic
Looking into the current session, Hologic Inc. (NASDAQ:HOLX) is trading at $76.64, after a 0.75% drop. Over the past month, the stock fell by 0.16%, but over the past year... 
Via Benzinga
Pause, breathe, learn: The importance of exploring breast cancer treatment options
(BPT) - A breast cancer diagnosis is scary, and women facing this situation are often laser-focused on eliminating the cancer as quickly as possible. However, if detected at an early stage, most women... 
Via Brandpoint
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
Hologic Q4 Sales Fell On Lower COVID-19 Assay Sales; Guides FY22 Ahead Of Consensus
Hologic Inc (NASDAQ: HOLX) posted fourth-quarter revenues of $1.32 billion, down 2.3% Y/Y but beating analysts' average estimate of $1.04 billion. The drop in... 
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.